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histologist's report and the immunologist's
functional finding. This is a mammoth task
when one realises that there were over 1500
references to be reviewed in the 1977 litera-
ture alone. It is not surprising, therefore, that
in this, his 3rd annual review, Clive Taylor
has invited other workers from the University
of California to assist.
The subject matter covers a wide range of
conditions which may be considered to fall
under the general heading of malignant
lymphoma, including lymphocytic leukaemias
and myeloma. The first third of the review
deals with surface marker, ultrastructure,
cytochemistry, genetic and kinetic studies of
lymphoid malignancies. The rest ofthe review
deals in detail with the pathological and
clinical aspects ofthe different disease groups.
The authors are to be congratulated that the
subjects are dealt with in a clear, easily read-
able style rather than a simple list of refer-
ences. Despite the high quality of the re-
viewers, after reading the chapter on the
pathologic classification of non-Hodgkin's
lymphoma, I felt that the quote of R. Willis
(1948) which opened Chapter 1 was still true:
"Nowhere in pathology has a chaos ofnames
so clouded clear concepts as in the subject of
lymphoid tumours".
Research workers and clinicians alike will
find this a valuable review of a difficult
subject.
J. H. SCARFFE
Breast Cancer. Advances in Research and
Treatment. Vol. 3-Current Topics.
Ed. W. L. McGUIRE (1979) New York:
Plenum Publishing Corp. 271pp. $39 50.
This is the third book in this series covering
all aspects of breast cancer; its subtitle
"Current Topics" aptly describes the range
ofcontributions to the book, and the chapters
are all written by experts in their particular
field. The authors give lucid evaluations ofthe
present state ofresearch intothebasic biology
of breast cancer and into modem techniques
ofassessment and treatment ofthe disease.
There are chapters on the factors in-
fluencing metastasis and on mechanisms of
tumour regression. Much attention is paid to
the effect of the hormone environment on the
natural history of the disease, in both males
and females. All are intriguing, as they pose
as many questions as they answer and they
pin-point avenues of future research.
The position of steroid-receptor analysis in
the assessment of breast cancer is well estab-
lished, and the chapter by the editor of this
book, Bill McGuire and his co-worker Gary
Chamness, gives a clear summary ofthe assay
methods available, and some of the pitfalls
that may be encountered by newcomers to
the field.
There is an interesting chapter on mam-
mography which summarizes the recent re-
ports on the risks and benefits from the pro-
cedure, and the author emphasizes the factors
that should be considered before launching
into screening programmes.
The real value of the book is that it has
been written by people actively involved in
their particular area of breast-cancer re-
search. Each author gives a comprehensive
literature survey and builds on that back-
ground to highlight the direction in which
they think that research should proceed in
the future.
D. BARNES
Carcinogenic Risks: Strategies for Inter-
vention. Proceedings of a Symposium
organised by IARC and l'Institut National
de la Sante et de le Recherche Medicale,
1979. Ed. W. DAVIES (1979) WHO.
283 pp. 50 Sw. Fr.
The object of the symposium was to high-
light experiences and problems in this subject
area which spans scientific, legislative and
public opinions. The reader is spared a
detailed description of legislative actions in
various countries, although sufficient infor-
mation is provided to give a flavour of the
legislative approach in France, Finland,
Sweden, the U.K. and U.S.A.
The proceedings of the symposium consist
of 25 papers organized into an introduction,
5 sections and a summing up, with each
section carrying a discussion summary. The
5 sections, on smoking, occupational risks,
food additives, drugs and pesticides, measure-
ment of carcinogenic risk and strategies of
intervention, use some of the problems and
paradoxes in the control of carcinogenic risks
to illustrate its complexity. A welcome
feature is the attempt by some speakers to
identify the role of scientists as those re-
sponsible for providing data which should be